Abstract
To maintain stable glucose level, diabetic patients should monitor and control their glucose levels several times a day through insulin injections. However, it is important to acknowledge that errors can occur during such a process, which may affect the desired outcomes. The artificial pancreas is designed to overcome such undesirable situations using a closed-loop control approach. The vital impressing challenge to closed-loop control is dealing with the complexity of glucose–insulin model, including model order and nonlinearity. This paper presents a closed-loop reduced multiple model predictive control to address these complexities, aiming to ease the monitoring and controlling glucose level in type 1 diabetic patients. Considering the influence of meal patterns on glucose control, the reduced model predictive control system is capable of effectively maintaining a safe and stable glucose level. Additionally, cost function in model predictive control could be defined to optimize both the insulin dosage and the glucose level, ensuring a well-balanced approach between the two. To assess the effectiveness of the proposed method, simulations using the Hovorka nonlinear glucose–insulin system are conducted in this regard.
Get full access to this article
View all access options for this article.
